<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(12)</volume><submitter>Mendonca DB</submitter><funding>Foundation for the National Institutes of Health</funding><pubmed_abstract>Regulation of mTOR signaling depends on an intricate interplay of post-translational protein modification. Recently, mEAK-7 (mTOR associated protein, eak-7 homolog) was identified as a positive activator of mTOR signaling via an alternative mTOR complex. However, the upstream regulation of mEAK-7 in human cells is not known. Because microRNAs are capable of modulating protein translation of RNA in eukaryotes, we conducted a bioinformatic search for relevant mEAK-7 targeting microRNAs using the Exiqon miRSearch V3.0 algorithm. Based on the score obtained through miRSearch V3.0, the top predicted miRNA (miR-1911-3p) was studied. miR-1911-3p mimics decreased protein levels of both mEAK-7 and mTORC1 downstream effectors p-S6 and p-4E-BP1 in non-small cell lung carcinoma (NSCLC) cell lines H1975 and H1299. miR-1911-3p levels and &lt;i>MEAK7&lt;/i> mRNA/mEAK-7/mTOR signaling levels were negatively correlated between normal lung and NSCLC cells. miR-1911-3p directly interacted with &lt;i>MEAK7&lt;/i> mRNA at the 3'-UTR to negatively regulate mEAK-7 and significantly decreased mTOR localization to the lysosome. Furthermore, miR-1911-3p significantly decreased cell proliferation and migration in both H1975 and H1299 cells. Thus, miR-1911-3p functions as a suppressor of mTOR signaling through the regulation of &lt;i>MEAK7&lt;/i> mRNA translation in human cancer cells.</pubmed_abstract><journal>Heliyon</journal><pagination>e05734</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7753913</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>MicroRNA-1911-3p targets mEAK-7 to suppress mTOR signaling in human lung cancer cells.</pubmed_title><pmcid>PMC7753913</pmcid><pubmed_authors>Krebsbach PH</pubmed_authors><pubmed_authors>Amatullah H</pubmed_authors><pubmed_authors>Haidar F</pubmed_authors><pubmed_authors>Kim JK</pubmed_authors><pubmed_authors>Mendonca DB</pubmed_authors><pubmed_authors>Fox AL</pubmed_authors><pubmed_authors>Nguyen JT</pubmed_authors><pubmed_authors>Ray C</pubmed_authors><pubmed_authors>Liu F</pubmed_authors></additional><is_claimable>false</is_claimable><name>MicroRNA-1911-3p targets mEAK-7 to suppress mTOR signaling in human lung cancer cells.</name><description>Regulation of mTOR signaling depends on an intricate interplay of post-translational protein modification. Recently, mEAK-7 (mTOR associated protein, eak-7 homolog) was identified as a positive activator of mTOR signaling via an alternative mTOR complex. However, the upstream regulation of mEAK-7 in human cells is not known. Because microRNAs are capable of modulating protein translation of RNA in eukaryotes, we conducted a bioinformatic search for relevant mEAK-7 targeting microRNAs using the Exiqon miRSearch V3.0 algorithm. Based on the score obtained through miRSearch V3.0, the top predicted miRNA (miR-1911-3p) was studied. miR-1911-3p mimics decreased protein levels of both mEAK-7 and mTORC1 downstream effectors p-S6 and p-4E-BP1 in non-small cell lung carcinoma (NSCLC) cell lines H1975 and H1299. miR-1911-3p levels and &lt;i>MEAK7&lt;/i> mRNA/mEAK-7/mTOR signaling levels were negatively correlated between normal lung and NSCLC cells. miR-1911-3p directly interacted with &lt;i>MEAK7&lt;/i> mRNA at the 3'-UTR to negatively regulate mEAK-7 and significantly decreased mTOR localization to the lysosome. Furthermore, miR-1911-3p significantly decreased cell proliferation and migration in both H1975 and H1299 cells. Thus, miR-1911-3p functions as a suppressor of mTOR signaling through the regulation of &lt;i>MEAK7&lt;/i> mRNA translation in human cancer cells.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Dec</publication><modification>2024-02-15T12:34:42.75Z</modification><creation>2021-02-20T16:47:28Z</creation></dates><accession>S-EPMC7753913</accession><cross_references><pubmed>33364499</pubmed><doi>10.1016/j.heliyon.2020.e05734</doi></cross_references></HashMap>